4//SEC Filing
SHREWSBURY STEPHEN B 4
Accession 0001209191-22-021673
CIK 0001445499other
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 9:54 PM ET
Size
6.8 KB
Accession
0001209191-22-021673
Insider Transaction Report
Form 4
SHREWSBURY STEPHEN B
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2022-03-29$1.97/sh+24,606$48,474→ 97,990 total - Exercise/Conversion
Stock Option (right to buy)
2022-03-29−24,606→ 0 totalExercise: $1.97Exp: 2027-02-13→ Common Stock (24,606 underlying)
Footnotes (1)
- [F1]The option is 100% vested and exercisable.
Documents
Issuer
IMPEL NEUROPHARMA INC
CIK 0001445499
Entity typeother
Related Parties
1- filerCIK 0001413821
Filing Metadata
- Form type
- 4
- Filed
- Mar 29, 8:00 PM ET
- Accepted
- Mar 30, 9:54 PM ET
- Size
- 6.8 KB